Patents by Inventor Tracey Jane Rhoades

Tracey Jane Rhoades has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
    Patent number: 8124124
    Abstract: A compressed tablet composition comprising: a granular component comprising a plurality of solidified melt granules of a non-steroidal anti-inflammatory drug (NSAID) having a melting point in the range 30-300° C. and incorporating a disintegrant uniformly dispersed therein; characterised in that the granules comprise a continuous phase of said non-steroidal anti-inflammatory drug and further characterised in that the tablet composition comprises silicon dioxide present in an amount of 0.05-5.0% by weight of the composition. Preferably, the composition also contains an extra-granular component comprising the silicon dioxide and a lubricant. Further preferably the NSAID is ibuprofen which has a melting point in the range 75-77° C. Optionally the melting process can be carried out in an extruder. Tablets containing advantageous processing properties and dissolution characteristics are obtained.
    Type: Grant
    Filed: November 30, 2000
    Date of Patent: February 28, 2012
    Assignee: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: Robert Arthur Sherry, Tracey Jane Rhoades, Frederick Raymond Higton
  • Therapeutic agents
    Publication number: 20030203026
    Abstract: A compressed tablet composition comprising: a granular component comprising a plurality of solidified melt granules of a non-steroidal anti-inflammatory drug (NSAID) having a melting point in the range 30-300° C. and incorporating a disintegrant uniformly dispersed therein; characterised in that the granules comprise a continuous phase of said non-steroidal anti-inflammatory drug and further characterised in that the tablet composition comprises silicon dioxide present in an amount of 0.05-5.0% by weight of the composition. Preferably, the composition also contains an extra-granular component comprising the silicon dioxide and a lubricant. Further preferably the NSAID is ibuprofen which has a melting point in the range 75-77° C. Optionally the melting process can be carried out in an extruder. Tablets containing advantageous processing properties and dissolution characteristics are obtained.
    Type: Application
    Filed: August 30, 2002
    Publication date: October 30, 2003
    Inventors: Robert Arthur Sherry, Tracey Jane Rhoades, Frederick Raymond Higton